A molecular imaging tool developed by researchers at UCLA and UCSF, helps improve the accuracy of predicting the risk of cancer recurrence in patients with intermediate to high-risk prostate cancer who undergo surgery.
_PMS295_3268-0120230724172765.png&width=400&height=400)
In a special forthcoming issue of the Journal of Multicultural Counseling and Development, a journal of the American Counseling Association (ACA), counseling and education researchers describe the distinct educational, vocational, psychological, social and health challenges that many Black men and boys face due to systemic racism and discrimination.
A technique that uses imaging technology as a guide can make radiation therapy safer for patients with prostate cancer by helping clinicians accurately aim radiation beams at the prostate while avoiding nearby tissue in the bladder, urethra, and rectum.
Babies are more likely to be born prematurely when either their father or mother has had a psychiatric diagnosis, according to a study.
Fathers’ as well as mothers’ psychiatric history is associated with preterm birth, according to a study published July 20th in the open access journal PLOS Medicine. The research shows for the first time that the risk of preterm birth is higher in infants whose fathers or mothers have psychiatric diagnoses, compared with those who do not, and where both parents have diagnoses, the risk is increased again.
The latest research in psychology and psychiatry on Newswise.
Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, today announced the first patient has been treated in the company's VAPOR 2 pivotal clinical study evaluating the safety and efficacy of its Vanquish minimally invasive water vapor ablation therapy for managing prostate cancer.
Ochsner Health announced today that it has become the first healthcare organization in Louisiana to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).
Three new biomarkers for prostate cancer have been identified to help pinpoint potentially aggressive cases of the disease, which kills 300,000 men each year.
Botswana-Rutgers Partnership for Health researchers review treatments that could improve outcomes for patients in a region where cancer rates are rising significantly.
Urotronic, Inc., a Minnesota-based medical device company pioneering the application of its drug-coated balloon technologies for use in interventional urology, today announced the world's first commercial procedure of the Optilume BPH® Catheter System to treat benign prostatic hyperplasia (BPH) was completed by Dr. Dean Elterman, urologist at University Urology Associates, in Toronto, Canada.
Researchers at Sylvester Comprehensive Cancer Center have developed a first-of-its-kind, orally administered drug to disrupt prostate cancer cells’ metabolism and deliver the chemotherapy agent cisplatin directly into treatment-resistant prostate cancer cells. The compound – Platin-L – works in two ways, breaking down a process that malignant prostate cancer cells use to fuel their growth, and delivering cisplatin directly into treatment-resistant cancer cells.
Melanoma, the most serious form of skin cancer, is highly treatable when detected early, but when the disease advances, it can lead to death. A new article published in the Journal of the American Academy of Dermatology reveals that men with melanoma — and particularly men with skin of color — are more likely to die than women with melanoma.
Urotronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval of its Optilume® BPH Catheter System, a unique minimally invasive surgical therapy (MIST) that combines mechanical dilation using a proprietary double-lobe balloon with concurrent localized delivery of paclitaxel for the treatment of lower urinary tract symptoms (LUTS) secondary to BPH.
Cancer Disparities: A new African Cancer Genome Registry at Sylvester Comprehensive Cancer Center in Miami seeks to find reasons for higher prostate and breast cancer rates in people of African ancestry. Dr. Sophia George, co-principal investigator, is available for interviews, as are two breast and prostate cancer study participants.
Fifty percent of patients with metastatic prostate cancer experience some level of financial hardship due to their treatment, according to a study in the August issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Moffitt Cancer Center researchers having been investigating what may trigger treatment related symptoms in patients with gynecologic cancers. In a new study published in the journal Cancers, they evaluated the relationship between inflammatory biomarkers and self-reported treatment related symptoms among this patient population.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for June 2023.
Data from a new study published in NEJM Evidence shows promise for personalized use of short term ADT in men with predominantly intermediate-risk prostate cancer. The information validates the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer.
A new study shows that an artificial intelligence (AI) model co-developed by researchers in the UCLA Jonsson Comprehensive Cancer Center and department of Urology at UCLA can help doctors determine the extent of cancer within the prostate.
Women with atrial fibrillation progress more rapidly to cognitive impairment and dementia than men with the heart rhythm condition, according to research presented today at ACNAP 2023, a scientific congress of the European Society of Cardiology (ESC)1 and published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
Neeraj Agarwal, MD, led a global study analyzing the combination of two cancer drugs to treat metastatic prostate cancer. Results showed this reduces the risk of cancer progression by 55%.
Jewel Kling, M.D., assistant director of the Women's Health Clinic at Mayo Clinic in Arizona, explains that stigma and discrimination create barriers to healthcare, placing the LGBTQ+ community at heightened risk for certain forms of cancer due to delayed cancer screenings as well as challenges with survivorship care.
As men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body’s ability to fight cancer, according to new research from Cedars-Sinai Cancer.
Irvine, Calif., June 21, 2023 — The process by which aged, or senescent, pigment-making cells in the skin cause significant growth of hair inside skin moles, called nevi, has been identified by a research team led by the University of California, Irvine. The discovery may offer a road map for an entirely new generation of molecular therapies for androgenetic alopecia, a common form of hair loss in both women and men.
Loyola Medicine Director of Male Reproductive Medicine Denise Asafu-Adjei, MD, MPH, is available to discuss the importance of men's health month.
Researchers at The University of Texas MD Anderson Cancer Center have uncovered a gene on the Y chromosome that is upregulated in KRAS-mutated colorectal cancer (CRC), increasing tumor cell invasiveness and reducing anti-tumor immunity in male patients.
Social isolation may negatively impact bone health, suggests a study conducted in mice being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Prenatal exposure to chemicals called phthalates, which are used in hundreds of products, may lead to hormonal changes in females that could affect their future fertility, suggests a study in mice being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
There may be hope for full recovery among men who wish to stop using anabolic-androgenic steroids for muscle growth, according to data being presented on Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Men were significantly more vulnerable than women to overdose deaths involving opioid and stimulant drugs in 2020-2021, according to a new study analyzing data from across the United States.
As we enter the summer months in the Northern Hemisphere and the possibility of extreme heat becomes more common, it’s important to stay up-to-date on the science of heat waves and take measures to protect ourselves from this growing public health threat.
Researchers develop new diagnostic tool to visualize protein biomarkers of well-developed sperm to determine if surgical sperm extraction may be successful for infertile men with nonobstructive azoospermia
Women and men who experience migraine headaches also carry an elevated risk of having an ischemic stroke, but women alone may carry an additional risk of heart attack and hemorrhagic stroke, according to a new study led by Cecilia Hvitfeldt Fuglsang of Aarhus University, Denmark publishing June 13th in the open access journal PLOS Medicine.
Prostate cancer is the most-commonly diagnosed malignancy and the second leading cause of cancer death among men in the United States. In its ever-indelicate world, the stubborn disease can continue to grow even when the amount of testosterone in the body is reduced to very low levels, thus earning the clumsy name: castrate-resistant prostate cancer (CRPC).
An interventional radiologist and a urologist with UHealth – University of Miami Health System and the Miller School of Medicine highlighted an innovative procedure to treat enlarged prostate glands at a June 5 Capitol Hill briefing on men’s health.
A new study in mice, led by researchers at Washington University School of Medicine in St. Louis, explains how prostate cancer senses a drop in testosterone levels due to common anti-hormone therapy and then begins making cholesterol — a necessary precursor to testosterone — to generate its own testosterone to fuel tumor growth. The study also points to a possible drug combination that may stop the cancer from feeding its own growth.
As more families consider bariatric surgery a viable option to treat their child’s obesity, it is important to stay up-to-date on the latest research on weight loss. You can find the latest research on bariatric surgery and other weight loss options in the Weight Loss channel on Newswise, where journalists can find story ideas on this trending topic.
For decades, people struggling with infertility had to add social stigma to problems. A Penn State Health doctor discusses the causes and treatments of infertility and how attitudes have shifted.
As men age, even those accustomed to good health may encounter symptoms that affect their quality of life and are important to mention to their physicians.
Colorectal cancer is on the rise among younger adults. According to the American Cancer Society, the proportion of cases among people under 55 increased from 11% in 1995 to 20% in 2019, and it is now the leading cause of cancer-related deaths for men younger than 50.
A medida que los hombres envejecen, incluso aquellos acostumbrados a una buena salud pueden desarrollar síntomas que afecten su calidad de vida y es importante que se los mencionen a sus médicos. Vikas Mehta, Licenciado en Medicina y Cirugía, un médico de Mayo Clinic Healthcare en Londres, describe varios signos físicos que vale la pena controlar.
À medida que os homens envelhecem, mesmo que eles levem uma vida saudável, podem surgir alguns sintomas que podem afetar sua qualidade de vida e devem ser relatados ao médico. O Dr. Vikas Mehta, bacharel em medicina e cirurgia da Mayo Clinic Healthcare em Londres, descreve vários sinais físicos que valem a pena acompanhar.
قد يواجه الرجال مع تقدمهم في العمر، بما فيهم أولئك الذين يتمتعون بصحة جيدة، أعراضًا تؤثر على جودة حياتهم، وعليهم أن يذكروها لأطبائهم. يصف الدكتور فيكاس ميهتا، بكالوريوس الطب والجراحة، وهو طبيب في مايو كلينك للرعاية الصحية بلندن، عددًا من المؤشرات الجسدية التي تستدعي المتابعة والفحص.
New research from Wake Forest University School of Medicine shows that American Indian and Alaska Native men are less likely to be screened for prostate cancer compared to other racial/ethnic groups. The study appears online in Cancer Causes & Control.
In addition to presenting Sylvester Comprehensive Cancer Center research findings, Sylvester experts are available at ASCO to share perspectives on a wide variety of topics and studies ranging from breast cancer to sarcoma, prostate cancer, mesothelioma, melanoma, CNS tumors and more.
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer, according to a multi-center study led by UC San Francisco and Stanford University, publishing June 1 in Nature Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
